Literature DB >> 3555102

Phenotyping of proliferating lymphocytes in angioimmunoblastic lymphadenopathy and related lesions by the double immunoenzymatic staining technique.

R Namikawa, T Suchi, R Ueda, G Itoh, K Koike, K Ota, T Takahashi.   

Abstract

Biopsy specimens of lymph nodes with the histologic characteristics of angioimmunoblastic lymphadenopathy with dysproteinemia (AILD) were obtained from 9 cases (4 cases of AILD and 5 cases of AILD-like T lymphoma [AILD-T]) and histologically analyzed by the use of a double immunoenzymatic staining technique with the combination of a monoclonal antibody against lymphocyte membrane antigen and that against human DNA polymerase alpha (pol alpha), which is detectable in the nucleus of the cells in G1, S, and G2 phases. In all 9 cases, the pol alpha + proliferating cells had a peripheral T-cell phenotype with T11 and Leu-4 antigens, whereas proliferating B cells with B1 antigen were rarely observed. As for T-cell subset antigens, the proliferating T cells had T4+ helper/inducer phenotype in 7 cases, while T8+ suppressor/killer T cells proliferated in 2 cases, although a significant number of T4+ proliferating cells were also recognized. The study on malignant lymphomas that evolved in the 2 cases showed that the T-subset antigens on major proliferating tumor cells were the same as those found in the preceding AILD lesions, suggesting that lymphoma T cells originate from the AILD lesion. The results suggested that AILD without histologic manifestations of malignancy and AILD-T may be a neoplastic disease derived from either subset of peripheral T cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3555102      PMCID: PMC1899736     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  19 in total

1.  Immunoblastic lymphadenopathy. A hyperimmune entity resembling Hodgkin's disease.

Authors:  R J Lukes; B H Tindle
Journal:  N Engl J Med       Date:  1975-01-02       Impact factor: 91.245

2.  Angio-immunoblastic lymphadenopathy with dysproteinaemia.

Authors:  G Frizzera; E M Moran; H Rappaport
Journal:  Lancet       Date:  1974-06-01       Impact factor: 79.321

3.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

4.  Angioimmunoblastic lymphadenopathy with dysproteinemia.

Authors:  L R Matz; J M Papadimitriou; J R Carroll; A L Barr; R L Dawkins; J M Jackson; R P Herrmann; B K Armstrong
Journal:  Cancer       Date:  1977-11       Impact factor: 6.860

5.  Intracellular localization of human DNA polymerase alpha with monoclonal antibodies.

Authors:  K G Bensch; S Tanaka; S Z Hu; T S Wang; D Korn
Journal:  J Biol Chem       Date:  1982-07-25       Impact factor: 5.157

6.  Malignant lymphoma arising in angioimmunoblastic lymphadenopathy.

Authors:  B N Nathwani; H Rappaport; E M Moran; G A Pangalis; H Kim
Journal:  Cancer       Date:  1978-02       Impact factor: 6.860

7.  Angio-immunoblastic lymphadenopathy. Diagnosis and clinical course.

Authors:  G Frizzera; E M Moran; H Rappaport
Journal:  Am J Med       Date:  1975-12       Impact factor: 4.965

8.  Preparation and preliminary characterization of monoclonal antibodies against human DNA polymerase alpha.

Authors:  S Tanaka; S Z Hu; T S Wang; D Korn
Journal:  J Biol Chem       Date:  1982-07-25       Impact factor: 5.157

9.  Angioimmunoblastic lymphadenopathy with paraproteinemia: a T- and B-cell disorder.

Authors:  A Klajman; A Yaretzky; M Schneider; Y Holoshitz; A Shneur; B Griffel
Journal:  Cancer       Date:  1981-12-01       Impact factor: 6.860

10.  Adult T cell lymphoma with hypergammaglobulinemia.

Authors:  S Watanabe; Y Shimosato; M Shimoyama; K Minato; M Suzuki; M Abe; T Nagatani
Journal:  Cancer       Date:  1980-12-01       Impact factor: 6.860

View more
  6 in total

Review 1.  Review: assessment of cell proliferation in histological material.

Authors:  P A Hall; D A Levison
Journal:  J Clin Pathol       Date:  1990-03       Impact factor: 3.411

2.  Atypical immunoproliferative disorders: when of age?

Authors:  G Frizzera
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

Review 3.  Histopathology and immunohistochemistry of peripheral T cell lymphomas: a proposal for their classification.

Authors:  T Suchi; K Lennert; L Y Tu; M Kikuchi; E Sato; A G Stansfeld; A C Feller
Journal:  J Clin Pathol       Date:  1987-09       Impact factor: 3.411

4.  Analysis of T-cell subpopulations in T-cell non-Hodgkin's lymphoma of angioimmunoblastic lymphadenopathy with dysproteinemia type by single target gene amplification of T cell receptor- beta gene rearrangements.

Authors:  K Willenbrock; A Roers; C Seidl; H H Wacker; R Küppers; M L Hansmann
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

5.  Genetic changes in atypical hyperplasia and lymphoma with angioimmunoblastic lymphadenopathy and dysproteinaemia in the same patients.

Authors:  K Ohshima; M Kikuchi; M Hashimoto; M Kozuru; N Uike; S Kobari; Y Masuda; Y Sumiyoshi; S Yoneda; M Takeshita
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

Review 6.  Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies.

Authors:  C Agostinelli; P P Piccaluga; P Went; M Rossi; A Gazzola; S Righi; T Sista; C Campidelli; P L Zinzani; B Falini; S A Pileri
Journal:  J Clin Pathol       Date:  2008-08-28       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.